{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:31:00Z","timestamp":1792773060199,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012652","name":"Eye Hospital Wenzhou Medical University","doi-asserted-by":"publisher","award":["KYQD20211003"],"award-info":[{"award-number":["KYQD20211003"]}],"id":[{"id":"10.13039\/100012652","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012652","name":"Eye Hospital Wenzhou Medical University","doi-asserted-by":"publisher","award":["KYQD20220101"],"award-info":[{"award-number":["KYQD20220101"]}],"id":[{"id":"10.13039\/100012652","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ22H120008"],"award-info":[{"award-number":["LQ22H120008"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019542","name":"Basic Research Project of Wenzhou City","doi-asserted-by":"publisher","award":["Y2023140"],"award-info":[{"award-number":["Y2023140"]}],"id":[{"id":"10.13039\/501100019542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijbiomac.2026.154101","type":"journal-article","created":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T21:57:07Z","timestamp":1786917427000},"page":"154101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["pH-Responsive hyaluronic acid-based nanoplatform for prolonged intraocular retention and synergistic chemotherapy of retinoblastoma"],"prefix":"10.1016","volume":"380","author":[{"given":"Zhihao","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyun","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cailing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6200-1007","authenticated-orcid":false,"given":"Ji-Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.154101_bb0005","doi-asserted-by":"crossref","first-page":"15021","DOI":"10.1038\/nrdp.2015.21","article-title":"Retinoblastoma","volume":"1","author":"Dimaras","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104423","article-title":"Safety of intravitreal chemotherapy in the management of retinoblastoma: a systematic review of the literature","volume":"200","author":"Lavasidis","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0015","article-title":"Biodegradable microspheres come into sight: a promising biomaterial for delivering drug to the posterior segment of the eyeball","volume":"27","author":"Xue","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0020","doi-asserted-by":"crossref","first-page":"6638","DOI":"10.1016\/j.apsb.2025.09.030","article-title":"Injectable hydrogel-mediated co-delivery of oncolytic adenovirus and melphalan for retinoblastoma control and vision preservation","volume":"15","author":"Wang","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.addr.2017.09.007","article-title":"In vitro and ex vivo models to study drug delivery barriers in the posterior segment of the eye","volume":"126","author":"Peynshaert","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0030","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.102117","article-title":"Nanomaterials in the diagnosis and treatment of ophthalmic diseases","volume":"54","author":"Ma","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0040","article-title":"Ocular nanomedicine","volume":"9","author":"Tang","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113939","article-title":"Intravitreal injection of cell membrane-coated nanoparticles for retinoblastoma treatment","volume":"385","author":"Zhang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2024.103200","article-title":"Intravitreal therapeutic nanoparticles for age-related macular degeneration: design principles, progress and opportunities","volume":"329","author":"Zhang","year":"2024","journal-title":"Adv. Colloid Interf. Sci."},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0055","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.drudis.2019.05.005","article-title":"Intravitreal nanoparticles for retinal delivery","volume":"24","author":"Huang","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202470194","article-title":"Innovative nanotechnology in drug delivery systems for advanced treatment of posterior segment ocular diseases","volume":"11","author":"Wu","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.biomaterials.2016.09.008","article-title":"Nanoparticle-protein complexes mimicking corona formation in ocular environment","volume":"109","author":"Jo","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0070","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2013.01.018","article-title":"Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo","volume":"167","author":"Xu","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0075","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1021\/acs.molpharmaceut.0c00411","article-title":"Diffusion and protein corona formation of lipid-based nanoparticles in the vitreous humor: profiling and pharmacokinetic considerations","volume":"18","author":"Tavakoli","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0080","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2204206","article-title":"Hyaluronic acid-based nanoparticles to deliver drugs to the ocular posterior segment","volume":"30","author":"Jiang","year":"2023","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0085","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1016\/j.biomaterials.2012.01.030","article-title":"The movement of self-assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection","volume":"33","author":"Koo","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0090","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jconrel.2011.06.031","article-title":"Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response","volume":"156","author":"Mizrahy","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12951-021-01221-8","article-title":"Charge reversal nano-systems for tumor therapy","volume":"20","author":"Zhang","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202407173","article-title":"The future of nanomaterials tackling the challenge of delivering nucleic acids to the retina","volume":"35","author":"Hurst","year":"2025","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202503776","article-title":"Tumor microenvironment-responsive polymer delivery platforms for cancer therapy","volume":"64","author":"Shi","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0110","doi-asserted-by":"crossref","first-page":"23223","DOI":"10.1021\/acsnano.3c06019","article-title":"Stimuli-responsive polymer-based nanosystems for cancer theranostics","volume":"17","author":"Wei","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0115","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1039\/D1CS00686J","article-title":"Polymer nano-systems for the encapsulation and delivery of active biomacromolecular therapeutic agents","volume":"51","author":"Machtakova","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0120","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41577-024-01026-4","article-title":"Cancer cell metabolism and antitumour immunity","volume":"24","author":"Martino","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202207973","article-title":"Smart nanosystems for overcoming multiple biological barriers in cancer nanomedicines transport: design principles, progress, and challenges","volume":"19","author":"Lin","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0130","doi-asserted-by":"crossref","first-page":"36926","DOI":"10.1021\/acsami.1c10328","article-title":"Use of pH-active catechol-bearing polymeric nanogels with glutathione-responsive dissociation to codeliver bortezomib and doxorubicin for the synergistic therapy of cancer","volume":"13","author":"Qiu","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0135","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jconrel.2022.05.056","article-title":"Preparation and application of pH-responsive drug delivery systems","volume":"348","author":"Ding","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0140","first-page":"102","article-title":"Enzyme-triggered deep tumor penetration of a dual-drug nanomedicine enables an enhanced cancer combination therapy","volume":"26","author":"Gu","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113985","article-title":"Drug development of lyso-thermosensitive liposomal doxorubicin: combining hyperthermia and thermosensitive drug delivery","volume":"178","author":"Borys","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0150","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jconrel.2024.11.001","article-title":"Injectable nanocomposite hydrogel with cascade drug release for treatment of uveal melanoma","volume":"376","author":"Guo","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0155","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.1002\/adfm.201603336","article-title":"Codelivery of a \u03c0-\u03c0 stacked dual anticancer drug combination with nanocarriers for overcoming multidrug resistance and tumor metastasis","volume":"26","author":"Wei","year":"2016","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114770","article-title":"Polymer- and lipid-based nanocarriers for ocular drug delivery: current status and future perspectives","volume":"196","author":"Han","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0165","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.biomaterials.2017.10.024","article-title":"Overcoming obstacles in the tumor microenvironment: recent advancements in nanoparticle delivery for cancer theranostics","volume":"156","author":"Overchuk","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0170","article-title":"Recent advances in nanomedicine for ocular fundus neovascularization disease management","volume":"13","author":"Zhou","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0175","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jconrel.2020.10.028","article-title":"Ocular barriers to retinal delivery of intravitreal liposomes: impact of vitreoretinal interface","volume":"328","author":"Tavakoli","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0180","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.drudis.2019.05.035","article-title":"Challenges and opportunities for drug delivery to the posterior of the eye","volume":"24","author":"Cabrera","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0190","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1167\/iovs.66.3.60","article-title":"Vitreous fibrillar structure and interfibrillar composition in adult mice","volume":"66","author":"Jaramillo-Garc\u00e9s","year":"2025","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijbiomac.2026.154101_bb0195","article-title":"Advances in targeted therapy for tumor with nanocarriers: a review","volume":"31","author":"Cheng","year":"2025","journal-title":"Mater. Today Bio"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302604047X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302604047X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:10:54Z","timestamp":1792764654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014181302604047X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":38,"alternative-id":["S014181302604047X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.154101","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"pH-Responsive hyaluronic acid-based nanoplatform for prolonged intraocular retention and synergistic chemotherapy of retinoblastoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.154101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154101"}}